A study led by MedUni Vienna showed that, due to the omicron variant of COVID-19, there is an increasing number of breakthrough infections in people with cancer, especially those undergoing cancer therapy.
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.
